Get a glimpse into our company and investor data—powered by the PitchBook Platform
Early Stage VCLATEST DEAL TYPE
$730KLATEST DEAL AMOUNT
Provider of pharmaceutical products designed to prevent obesity. The company's pharmaceutical products engages in development and discovery of therapies for non-alcoholic fatty liver disease and hepatic steatosis.